Twenty-seven years of involvement, observation and assessment of alternative medical practices, providers and institutions in Mexico, the US, Canada, and Europe inform our Alternative Cancer Treatment & Education Program (AltCTEP). Our long-time US federal advisory work with health-related agencies (the US Congressional Office of Technology Assessment, the Office of the Director of the National Institutes of Health, the Office of Alternative Medicine, the National Center for Complementary and Alternative Medicine, the Food and Drug Administration, the Health Care Finance Administration, etc.) has led to our conviction that most standard and nonstandard methods of cancer management are limited in their effectiveness.

We have identified and integrated a number of non-proprietary cancer treatments, each of which has produced long-term disease-free survivals. Our parent non-profit, the Gerson Research Organization, has created Gar Hildenbrand Alternatives to help connect patients with these effective cancer treatments, which are not available in standard cancer care. While it is best to treat all cancers early, even if your disease is advanced, recurrent, and you have run out of standard treatment options, feel free to contact us. And please review the information and links to articles in this website.

The Gerson Research Organization is a US 501 (c)(3), tax-exempt, scientific research organization incorporated in 1993.